Robert Hogg

Получаване на мой собствен потребителски профил

Позовавания

	Всички	От 2019
Позовавания	63109	19184
h-индекс	116	57
i10-индекс	574	328

4000

2000

1000

3000

199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024161 277 446 475 606 878 1166 1378 1566 1599 1929 2005 2617 2845 3197 3270 3309 3549 3464 3995 3920 3668 3692 3745 3433 2837 1793

Публичен достъп

Преглед на всички

325 статии

51 статии

налични

неналични

Въз основа на изисквания при финансирането

Съавтори

Dr. Julio Montaner, OC, OBC, MD, FR...Director of the BC-CfE; Director of IDC and Physician Program Director for HIV/AIDS PHCПотвърден имейл адрес: bccfe.ca
Martin T. SchechterProfessor of Population and Public Health, University of British ColumbiaПотвърден имейл адрес: ubc.ca
Viviane Dias LimaBC Centre for Excellence in HIV/AIDS & University of British ColumbiaПотвърден имейл адрес: bccfe.ca
Keith Chanprecision heorПотвърден имейл адрес: precisionvh.com
David MooreUniversity of British ColumbiaПотвърден имейл адрес: bccfe.ca
Nathan LachowskyUniversity of VictoriaПотвърден имейл адрес: uvic.ca
Mark TyndallProfessor, School of Population and Public Health, UBCПотвърден имейл адрес: ubc.ca
Steffanie A StrathdeeUniversity of California San DiegoПотвърден имейл адрес: ucsd.edu
Kate SaltersSimon Fraser UniversityПотвърден имейл адрес: sfu.ca
Kiffer G. CardFaculty of Health Sciences, Simon Fraser UniversityПотвърден имейл адрес: sfu.ca
Mona LoutfyWomen's College HospitalПотвърден имейл адрес: wchospital.ca
David BangsbergProvost and Dean College of Health Sciences, VinUniversityПотвърден имейл адрес: vinuni.edu.vn
Arn (Arnold) James SchilderBC Centre for Excellence in HIV/AIDS, Providence Health Care Society,Потвърден имейл адрес: cfenet.ubc.ca
Janet RaboudUniversity Health NetworkПотвърден имейл адрес: raboud.net
Anita PalepuProfessor of Medicine, University of British ColumbiaПотвърден имейл адрес: hivnet.ubc.ca
Jonathan SterneProfessor of Medical Statistics and Epidemiology, University of BristolПотвърден имейл адрес: bristol.ac.uk
Hasina SamjiBC Centre for Disease ControlПотвърден имейл адрес: bccdc.ca
Ashleigh J RichDuke University School of NursingПотвърден имейл адрес: duke.edu
Zabrina BrummeAssociate Professor, Faculty of Health Sciences, Simon Fraser UniversityПотвърден имейл адрес: sfu.ca
Chanson BrummeAssistant Professor, Faculty of Medicine, University of British ColumbiaПотвърден имейл адрес: bccfe.ca

Следене

Robert Hogg

Faculty of Health Sciences, Simon Fraser University

Потвърден имейл адрес: sfu.ca - Начална страница

Demography Population Health HIV


Заглавие Сортиране по цитати Сортиране по година Сортиране по заглавие	Позовавания Позовавания	Година
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global … H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ... The lancet 388 (10053), 1459-1544, 2016	5498	2016
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies M Egger, M May, G Chêne, AN Phillips, B Ledergerber, F Dabis, ... The Lancet 360 (9327), 119-129, 2002	2119	2002
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. TCC Antiretroviral Lancet 372 (9635), 293, 2008	2041	2008
Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada H Samji, A Cescon, RS Hogg, SP Modur, KN Althoff, K Buchacz, ... PloS one 8 (12), e81355, 2013	1652	2013
Effect of early versus deferred antiretroviral therapy for HIV on survival MM Kitahata, SJ Gange, AG Abraham, B Merriman, MS Saag, AC Justice, ... New England Journal of Medicine 360 (18), 1815-1826, 2009	1619	2009
Improved survival among HIV-infected individuals following initiation of antiretroviral therapy RS Hogg, KV Heath, B Yip, KJP Craib, MV O'shaughnessy, MT Schechter, ... Jama 279 (6), 450-454, 1998	1113	1998
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies When To Start Consortium The Lancet 373 (9672), 1352-1363, 2009	1031	2009
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy RS Hogg, B Yip, KJ Chan, E Wood, KJP Craib, MV O'Shaughnessy, ... Jama 286 (20), 2568-2577, 2001	1017	2001
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study JSG Montaner, VD Lima, R Barrios, B Yip, E Wood, T Kerr, K Shannon, ... The Lancet 376 (9740), 532-539, 2010	965	2010
Causes of death in HIV-1–infected patients treated with antiretroviral therapy, 1996–2006: Collaborative analysis of 13 HIV cohort studies ATC Collaboration Clinical infectious diseases: an official publication of the Infectious …, 2010	757	2010
Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada W Zhang, N O’Brien, JI Forrest, KA Salters, TL Patterson, JSG Montaner, ... PloS one 7 (7), e40793, 2012	739	2012
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic JSG Montaner, R Hogg, E Wood, T Kerr, M Tyndall, AR Levy, PR Harrigan The Lancet 368 (9534), 531-536, 2006	696	2006
Barriers to use of free antiretroviral therapy in injection drug users SA Strathdee, A Palepu, PGA Cornelisse, B Yip, MV O'Shaughnessy, ... Jama 280 (6), 547-549, 1998	603	1998
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy PR Harrigan, RS Hogg, WWY Dong, B Yip, B Wynhoven, J Woodward, ... The Journal of infectious diseases 191 (3), 339-347, 2005	561	2005
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up RS Hogg, K Heath, D Bangsberg, B Yip, N Press, MV O'Shaughnessy, ... Aids 16 (7), 1051-1058, 2002	553	2002
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda EJ Mills, C Bakanda, J Birungi, K Chan, N Ford, CL Cooper, JB Nachega, ... Annals of internal medicine 155 (4), 209-216, 2011	543	2011
Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350× 109 cells/L E Wood, RS Hogg, B Yip, PR Harrigan, MV O'Shaughnessy, ... Annals of internal medicine 139 (10), 810-816, 2003	487	2003
Decline in deaths from AIDS due to new antiretrovirals RS Hogg, MV O'Shaughnessy, N Gataric, B Yip, K Craib, MT Schechter, ... The Lancet 349 (9061), 1294, 1997	466	1997
Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV Treatment as Prevention” experience in a … JSG Montaner, VD Lima, PR Harrigan, L Lourenço, B Yip, B Nosyk, ... PloS one 9 (2), e87872, 2014	452	2014
Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens RS Hogg, B Yip, C Kully, KJP Craib, MV O'Shaughnessy, MT Schechter, ... Cmaj 160 (5), 659-665, 1999	446	1999

Системата не може да изпълни операцията сега. Опитайте отново по-късно.

Статии 1–20

Позовавания годишно

Дублирани описания

Обединени библиографски описания

Добавяне на съавториСъавтори

Следене

Позовавания

Съавтори